{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:17:00Z","timestamp":1793834220718,"version":"4.6.1"},"reference-count":130,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T00:00:00Z","timestamp":1696550400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8227392"],"award-info":[{"award-number":["8227392"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273928"],"award-info":[{"award-number":["82273928"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U21A20339"],"award-info":[{"award-number":["U21A20339"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Non-coding RNA Research"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.ncrna.2023.10.002","type":"journal-article","created":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T03:32:03Z","timestamp":1696649523000},"page":"661-674","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Methods of miRNA delivery and possibilities of their application in neuro-oncology"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4965-0835","authenticated-orcid":false,"given":"Ilgiz","family":"Gareev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozal","family":"Beylerli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasim","family":"Tamrazov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Ilyasova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Shumadalova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baofeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ncrna.2023.10.002_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.740303","article-title":"The role of MicroRNAs in therapeutic resistance of malignant primary brain tumors","volume":"9","author":"Gareev","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"4","key":"10.1016\/j.ncrna.2023.10.002_bib2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ncrna.2022.09.001","article-title":"MicroRNAs-mediated regulation of glucose transporter (GLUT) expression in glioblastoma","volume":"7","author":"Beylerli","year":"2022","journal-title":"Noncoding RNA Res."},{"issue":"3","key":"10.1016\/j.ncrna.2023.10.002_bib3","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10238-020-00627-2","article-title":"The current state of MiRNAs as biomarkers and therapeutic tools","volume":"20","author":"Gareev","year":"2020","journal-title":"Clin. Exp. Med."},{"issue":"19","key":"10.1016\/j.ncrna.2023.10.002_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911502","article-title":"miRNA: a promising therapeutic target in cancer","volume":"23","author":"Menon","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ncrna.2023.10.002_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114113","article-title":"RNAi-based therapeutics and tumor targeted delivery in cancer","volume":"182","author":"Kara","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.ncrna.2023.10.002_bib6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12987-020-00230-3","article-title":"A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity","volume":"17","author":"Kadry","year":"2020","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.ncrna.2023.10.002_bib7","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.63253","article-title":"Nano-scale architecture of blood-brain barrier tight-junctions","volume":"10","author":"Sasson","year":"2021","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.ncrna.2023.10.002_bib8","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.2119\/molmed.2012.00015","article-title":"Different aquaporin-4 expression in glioblastoma multiforme patients with and without seizures","volume":"18","author":"Isoardo","year":"2012","journal-title":"Mol. Med."},{"issue":"1","key":"10.1016\/j.ncrna.2023.10.002_bib9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41568-019-0205-x","article-title":"The blood-brain barrier and blood-tumour barrier in brain tumours and metastases","volume":"20","author":"Arvanitis","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.ncrna.2023.10.002_bib10","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1016\/j.apsb.2020.11.023","article-title":"Evolution of blood-brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies","volume":"11","author":"Han","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.ncrna.2023.10.002_bib11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13045-021-01096-0","article-title":"Nanomaterials for cancer therapy: current progress and perspectives","volume":"14","author":"Cheng","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"23","key":"10.1016\/j.ncrna.2023.10.002_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312654","article-title":"Blood-brain barrier in brain tumors: biology and clinical relevance","volume":"22","author":"Mo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ncrna.2023.10.002_bib13","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/320941","article-title":"Blood brain barrier: a challenge for effectual therapy of brain tumors","author":"Bhowmik","year":"2015","journal-title":"BioMed Res. Int."},{"issue":"8","key":"10.1016\/j.ncrna.2023.10.002_bib14","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.trecan.2020.04.007","article-title":"Genes that mediate metastasis across the blood-brain barrier","volume":"6","author":"Fares","year":"2020","journal-title":"Trends Cancer"},{"issue":"12","key":"10.1016\/j.ncrna.2023.10.002_bib15","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1093\/neuonc\/noab022","article-title":"Blood-brain barrier alterations in human brain tumors revealed by genome-wide transcriptomic profiling","volume":"23","author":"Schaffenrath","year":"2021","journal-title":"Neuro Oncol."},{"issue":"3","key":"10.1016\/j.ncrna.2023.10.002_bib16","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ccell.2017.02.009","article-title":"The microenvironmental landscape of brain tumors","volume":"31","author":"Quail","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ncrna.2023.10.002_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2019.101896","article-title":"Molecular targeted therapy of glioblastoma","volume":"80","author":"Le Rhun","year":"2019","journal-title":"Cancer Treat Rev."},{"issue":"27","key":"10.1016\/j.ncrna.2023.10.002_bib18","doi-asserted-by":"crossref","first-page":"31371","DOI":"10.1021\/acsami.1c00388","article-title":"Cancer cell-sticky hydrogels to target the cell membrane of invading glioblastomas","volume":"13","author":"Cha","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ncrna.2023.10.002_bib19","article-title":"Application of cell membrane-functionalized biomimetic nanoparticles in the treatment of glioma","author":"Zhang","year":"2023","journal-title":"J. Mater. Chem. B"},{"issue":"1","key":"10.1016\/j.ncrna.2023.10.002_bib20","first-page":"23","article-title":"Cholesterol metabolism and tumor","volume":"50","author":"Meng","year":"2021","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"issue":"4","key":"10.1016\/j.ncrna.2023.10.002_bib21","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1158\/2159-8290.CD-22-0455","article-title":"Targeting microglial metabolic rewiring synergizes with immune-checkpoint blockade therapy for glioblastoma","volume":"13","author":"Ye","year":"2023","journal-title":"Cancer Discov."},{"issue":"8","key":"10.1016\/j.ncrna.2023.10.002_bib22","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.3390\/biomedicines10081943","article-title":"Lipid metabolism in glioblastoma: from de novo synthesis to storage","volume":"10","author":"Kou","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.ncrna.2023.10.002_bib23","doi-asserted-by":"crossref","DOI":"10.1097\/CAD.0000000000001533","article-title":"The effects of statin therapy on brain tumors, particularly glioma: a review","author":"Alrosan","year":"2023","journal-title":"Anti Cancer Drugs"},{"issue":"2","key":"10.1016\/j.ncrna.2023.10.002_bib24","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.gendis.2015.02.001","article-title":"Glioblastoma stem cells (GSCs) epigenetic plasticity and interconversion between differentiated non-GSCs and GSCs","volume":"2","author":"Safa","year":"2015","journal-title":"Genes Dis"},{"key":"10.1016\/j.ncrna.2023.10.002_bib25","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/4085039","article-title":"The expression profile of miRNA in glioma and the role of miR-339-5p in glioma","author":"Lin","year":"2022","journal-title":"BioMed Res. Int."},{"issue":"8","key":"10.1016\/j.ncrna.2023.10.002_bib26","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1080\/15476286.2015.1020270","article-title":"Passenger strand loading in overexpression experiments using microRNA mimics","volume":"12","author":"S\u00f8kilde","year":"2015","journal-title":"RNA Biol."},{"issue":"1","key":"10.1016\/j.ncrna.2023.10.002_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1261\/rna.068692.118","article-title":"Post-transcriptional control of miRNA biogenesis","volume":"25","author":"Michlewski","year":"2019","journal-title":"RNA"},{"issue":"3","key":"10.1016\/j.ncrna.2023.10.002_bib28","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.trecan.2017.12.008","article-title":"MicroRNA-based drugs for brain tumors","volume":"4","author":"Anthiya","year":"2018","journal-title":"Trends Cancer"},{"issue":"3","key":"10.1016\/j.ncrna.2023.10.002_bib29","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrd.2016.117","article-title":"Non-coding RNAs as drug targets","volume":"16","author":"Matsui","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.ncrna.2023.10.002_bib30","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ncrna.2022.02.005","article-title":"The role of microRNA in the pathogenesis of glial brain tumors","volume":"7","author":"Beylerli","year":"2022","journal-title":"Noncoding RNA Res."},{"issue":"6","key":"10.1016\/j.ncrna.2023.10.002_bib31","doi-asserted-by":"crossref","first-page":"62","DOI":"10.14715\/cmb\/2021.67.9","article-title":"Long-stranded non-coding RNA HCG11 regulates glioma cell proliferation, apoptosis and drug resistance via the sponge MicroRNA-144COX-2 axis","volume":"67","author":"Jiang","year":"2022","journal-title":"Cell. Mol. Biol."},{"key":"10.1016\/j.ncrna.2023.10.002_bib32","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/978-1-0716-2707-5_12","article-title":"Locked nucleic acid AntimiR therapy for the heart","volume":"2573","author":"Samolovac","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ncrna.2023.10.002_bib33","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.2147\/IJN.S182384","article-title":"Exosome-mediated delivery of functionally active miRNA-142-3p inhibitor reduces tumorigenicity of breast cancer in vitro and in vivo","volume":"13","author":"Naseri","year":"2018","journal-title":"Int. J. Nanomed."},{"issue":"5","key":"10.1016\/j.ncrna.2023.10.002_bib34","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41576-021-00439-4","article-title":"Drug delivery systems for RNA therapeutics","volume":"23","author":"Paunovska","year":"2022","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ncrna.2023.10.002_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113834","article-title":"Nucleic acid delivery for therapeutic applications","volume":"178","author":"Gupta","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.ncrna.2023.10.002_bib36","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/15476286.2021.2021650","article-title":"RNA-based therapeutics for neurological diseases","volume":"19","author":"Anthony","year":"2022","journal-title":"RNA Biol."},{"issue":"13","key":"10.1016\/j.ncrna.2023.10.002_bib37","doi-asserted-by":"crossref","first-page":"7167","DOI":"10.3390\/ijms23137167","article-title":"MicroRNA-based diagnosis and therapy","volume":"23","author":"Ho","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"23","key":"10.1016\/j.ncrna.2023.10.002_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314954","article-title":"miRNA pathway alteration in response to non-coding RNA delivery in viral vector-based gene therapy","volume":"23","author":"Savenkova","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ncrna.2023.10.002_bib39","article-title":"Viral vectors for gene transfer","volume":"8","author":"Chen","year":"2018","journal-title":"Curr. Protoc. Mol. Biol."},{"issue":"7","key":"10.1016\/j.ncrna.2023.10.002_bib40","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1134\/S0006297916070063","article-title":"Viral vectors for gene therapy: current state and clinical perspectives","volume":"81","author":"Lukashev","year":"2016","journal-title":"Biochemistry (Mosc.)"},{"issue":"8","key":"10.1016\/j.ncrna.2023.10.002_bib41","first-page":"2972","article-title":"MiR-28-5p promotes human glioblastoma cell growth through inactivation of FOXO1","volume":"12","author":"Zhu","year":"2019","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"12","key":"10.1016\/j.ncrna.2023.10.002_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189353","article-title":"Hexokinase 2 (HK2), the tumor promoter in glioma, is downregulated by miR-218\/Bmi1 pathway","volume":"12","author":"Liu","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ncrna.2023.10.002_bib43","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.3892\/mmr.2013.1639","article-title":"miR-218 is downregulated and directly targets SH3GL1 in childhood medulloblastoma","volume":"8","author":"Shi","year":"2013","journal-title":"Mol. Med. Rep."},{"issue":"6","key":"10.1016\/j.ncrna.2023.10.002_bib44","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/bpa.12136","article-title":"MiR-22 is frequently downregulated in medulloblastomas and inhibits cell proliferation via the novel target PAPST1","volume":"24","author":"Xu","year":"2014","journal-title":"Brain Pathol."},{"issue":"3","key":"10.1016\/j.ncrna.2023.10.002_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004998","article-title":"MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma","volume":"4","author":"Garzia","year":"2009","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.ncrna.2023.10.002_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024584","article-title":"MiR-34a targeting of Notch ligand delta-like 1 impairs CD15+\/CD133+ tumor-propagating cells and supports neural differentiation in medulloblastoma","volume":"6","author":"de Antonellis","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ncrna.2023.10.002_bib47","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.3892\/mmr.2014.2412","article-title":"microRNA response element-regulated TIKI2 expression suppresses the tumorigencity of malignant gliomas","volume":"10","author":"Li","year":"2014","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.ncrna.2023.10.002_bib48","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/mt.2014.177","article-title":"Use of miRNA response sequences to block off-target replication and increase the safety of an unattenuated, glioblastoma-targeted oncolytic HSV","volume":"23","author":"Mazzacurati","year":"2015","journal-title":"Mol. Ther."},{"issue":"10","key":"10.1016\/j.ncrna.2023.10.002_bib49","doi-asserted-by":"crossref","first-page":"e398","DOI":"10.1038\/cddis.2012.134","article-title":"MicroRNA-10b pleiotropically regulates invasion, angiogenicity and apoptosis of tumor cells resembling mesenchymal subtype of glioblastoma multiforme","volume":"3","author":"Lin","year":"2012","journal-title":"Cell Death Dis."},{"issue":"8","key":"10.1016\/j.ncrna.2023.10.002_bib50","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.3390\/v13081526","article-title":"Designing lentiviral vectors for gene therapy of genetic diseases","volume":"13","author":"Poletti","year":"2021","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.ncrna.2023.10.002_bib51","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1089\/nat.2014.0486","article-title":"Gamma-retroviral vector design for the co-expression of artificial microRNAs and therapeutic proteins","volume":"24","author":"Park","year":"2014","journal-title":"Nucleic Acid Therapeut."},{"issue":"7","key":"10.1016\/j.ncrna.2023.10.002_bib52","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s41375-018-0106-0","article-title":"Clinical use of lentiviral vectors","volume":"32","author":"Milone","year":"2018","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.ncrna.2023.10.002_bib53","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3390\/cancers11030417","article-title":"Lentiviral vectors as tools for the study and treatment of glioblastoma","volume":"11","author":"Del Vecchio","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.ncrna.2023.10.002_bib54","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-1-4939-3271-9_8","article-title":"Lentivirus production and purification","volume":"1382","author":"Benskey","year":"2016","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.ncrna.2023.10.002_bib55","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13045-018-0618-0","article-title":"miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3\/Bcl2 signaling pathway","volume":"11","author":"Li","year":"2018","journal-title":"J. Hematol. Oncol."},{"issue":"7","key":"10.1016\/j.ncrna.2023.10.002_bib56","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1055\/s-0043-106437","article-title":"MicroRNA-524-5p functions as a tumor suppressor in a human pituitary tumor-derived cell line","volume":"49","author":"Zhen","year":"2017","journal-title":"Horm. Metab. Res."},{"issue":"10","key":"10.1016\/j.ncrna.2023.10.002_bib57","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.3390\/ijms21103643","article-title":"High-capacity adenoviral vectors: expanding the scope of gene therapy","volume":"21","author":"Ricobaraza","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.ncrna.2023.10.002_bib58","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.3390\/v13122502","article-title":"Adenovirus biology, recombinant adenovirus, and adenovirus usage in gene therapy","volume":"13","author":"Watanabe","year":"2021","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.ncrna.2023.10.002_bib59","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2144\/btn-2022-0051","article-title":"Adenovirus vector system: construction, history and therapeutic applications","volume":"73","author":"Syyam","year":"2022","journal-title":"Biotechniques"},{"issue":"5","key":"10.1016\/j.ncrna.2023.10.002_bib60","first-page":"530","article-title":"Oncolytic adenoviruses for the treatment of brain tumors","volume":"12","author":"Gomez-Manzano","year":"2010","journal-title":"Curr. Opin. Mol. Therapeut."},{"key":"10.1016\/j.ncrna.2023.10.002_bib61","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.virol.2014.04.007","article-title":"The application of multiple miRNA response elements enables oncolytic adenoviruses to possess specificity to glioma cells","volume":"458\u2013459","author":"Yao","year":"2014","journal-title":"Virology"},{"issue":"7\u20138","key":"10.1016\/j.ncrna.2023.10.002_bib62","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1089\/hum.2022.050","article-title":"Human and insect cell-produced recombinant adeno-associated viruses show differences in genome heterogeneity","volume":"33","author":"Tran","year":"2022","journal-title":"Hum. Gene Ther."},{"issue":"4","key":"10.1016\/j.ncrna.2023.10.002_bib63","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40259-017-0234-5","article-title":"Adeno-associated virus (AAV) as a vector for gene therapy","volume":"31","author":"Naso","year":"2017","journal-title":"BioDrugs"},{"issue":"5","key":"10.1016\/j.ncrna.2023.10.002_bib64","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.tim.2021.09.005","article-title":"Adeno-associated virus (AAV) cell entry: structural insights","volume":"30","author":"Meyer","year":"2022","journal-title":"Trends Microbiol."},{"issue":"2","key":"10.1016\/j.ncrna.2023.10.002_bib65","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/neuonc\/nox138","article-title":"microRNA-7 upregulates death receptor 5 and primes resistant brain tumors to caspase-mediated apoptosis","volume":"20","author":"Bhere","year":"2018","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.ncrna.2023.10.002_bib66","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.coviro.2016.08.007","article-title":"Retargeting of herpes simplex virus (HSV) vectors","volume":"21","author":"Goins","year":"2016","journal-title":"Curr Opin Virol"},{"issue":"1","key":"10.1016\/j.ncrna.2023.10.002_bib67","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02856-18","article-title":"Herpes simplex virus 1 lytic infection blocks MicroRNA (miRNA) biogenesis at the stage of nuclear export of pre-miRNAs","volume":"10","author":"Pan","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.ncrna.2023.10.002_bib68","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.omto.2020.08.004","article-title":"Design of an interferon-resistant oncolytic HSV-1 incorporating redundant safety modalities for improved tolerability","volume":"18","author":"Kennedy","year":"2020","journal-title":"Mol Ther Oncolytics"},{"issue":"10","key":"10.1016\/j.ncrna.2023.10.002_bib69","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1158\/1078-0432.CCR-19-3420","article-title":"Oncolytic HSV-infected glioma cells activate NOTCH in adjacent tumor cells sensitizing tumors to gamma secretase inhibition","volume":"26","author":"Otani","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.ncrna.2023.10.002_bib70","doi-asserted-by":"crossref","first-page":"608","DOI":"10.3390\/v15030608","article-title":"Evaluation of Baculoviruses as gene therapy vectors for brain cancer","volume":"15","author":"Garcia Fallit","year":"2023","journal-title":"Viruses"},{"issue":"9","key":"10.1016\/j.ncrna.2023.10.002_bib71","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3390\/v10090510","article-title":"Baculovirus as a tool for gene delivery and gene therapy","volume":"10","author":"Ono","year":"2018","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.ncrna.2023.10.002_bib72","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/mt.2012.286","article-title":"Baculovirus: an insect-derived vector for diverse gene transfer applications","volume":"21","author":"Airenne","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ncrna.2023.10.002_bib73","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jconrel.2022.01.008","article-title":"Non-viral vectors for RNA delivery","volume":"342","author":"Yan","year":"2022","journal-title":"J. Contr. Release"},{"issue":"4","key":"10.1016\/j.ncrna.2023.10.002_bib74","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1208\/s12248-021-00608-7","article-title":"Non-viral vectors in gene therapy: recent development, challenges, and prospects","volume":"23","author":"Zu","year":"2021","journal-title":"AAPS J."},{"key":"10.1016\/j.ncrna.2023.10.002_bib75","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.2147\/IJN.S241055","article-title":"Brain targeted gold liposomes improve RNAi delivery for glioblastoma","volume":"15","author":"Grafals-Ruiz","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ncrna.2023.10.002_bib76","first-page":"3880","article-title":"MiRNA-323-5p promotes U373 cell apoptosis by reducing IGF-1R","volume":"21","author":"Yang","year":"2015","journal-title":"Med. Sci. Mon. Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.ncrna.2023.10.002_bib77","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jconrel.2015.04.002","article-title":"MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: a new multimodal gene therapy approach for glioblastoma","volume":"207","author":"Costa","year":"2015","journal-title":"J. Contr. Release"},{"issue":"9","key":"10.1016\/j.ncrna.2023.10.002_bib78","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1166\/jbn.2016.2274","article-title":"Modulation of MicroRNAs 34a and 21 affects viability, senescence, and invasion in glioblastoma multiforme","volume":"12","author":"Yin","year":"2016","journal-title":"J. Biomed. Nanotechnol."},{"issue":"4","key":"10.1016\/j.ncrna.2023.10.002_bib79","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.3892\/or.2013.2283","article-title":"Poly(amido amine) is an ideal carrier of miR-7 for enhancing gene silencing effects on the EGFR pathway in U251 glioma cells","volume":"29","author":"Liu","year":"2013","journal-title":"Oncol. Rep."},{"issue":"2","key":"10.1016\/j.ncrna.2023.10.002_bib80","first-page":"198","article-title":"[Expression of hsa-miR-20a in human glioma tissues and its effect on the proliferation of human glioma cells in vitro]","volume":"32","author":"Yao","year":"2012","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"issue":"5","key":"10.1016\/j.ncrna.2023.10.002_bib81","first-page":"325","article-title":"[Inhibitory effect of folic acid\/polyamide-amine as a miR-7 vector on the growth of glioma in mice]","volume":"34","author":"Liu","year":"2012","journal-title":"Zhonghua Zhongliu Zazhi"},{"key":"10.1016\/j.ncrna.2023.10.002_bib82","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.peptides.2014.06.008","article-title":"Arginine-rich, cell penetrating peptide-anti-microRNA complexes decrease glioblastoma migration potential","volume":"58","author":"Zhang","year":"2014","journal-title":"Peptides"},{"key":"10.1016\/j.ncrna.2023.10.002_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118789","article-title":"Efficient delivery of anti-miR-210 using Tachyplesin, a cell penetrating peptide, for glioblastoma treatment","volume":"572","author":"Jana","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.ncrna.2023.10.002_bib84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098473","article-title":"The NFL-TBS.40-63 anti-glioblastoma peptide disrupts microtubule and mitochondrial networks in the T98G glioma cell line","volume":"9","author":"Rivalin","year":"2014","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.ncrna.2023.10.002_bib85","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1021\/acs.molpharmaceut.5b00694","article-title":"Nanoparticle-delivered antisense MicroRNA-21 enhances the effects of temozolomide on glioblastoma cells","volume":"12","author":"Ananta","year":"2015","journal-title":"Mol. Pharm."},{"issue":"5","key":"10.1016\/j.ncrna.2023.10.002_bib86","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.biomaterials.2011.10.071","article-title":"Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI","volume":"33","author":"Yang","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.ncrna.2023.10.002_bib87","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/978-1-62703-462-3_21","article-title":"Lipid-based nanoparticles as nonviral gene delivery vectors","volume":"1025","author":"Pezzoli","year":"2013","journal-title":"Methods Mol. Biol."},{"issue":"7","key":"10.1016\/j.ncrna.2023.10.002_bib88","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.3390\/pharmaceutics14071482","article-title":"A quality by design approach in pharmaceutical development of non-viral vectors with a focus on miRNA","volume":"14","author":"Toma","year":"2022","journal-title":"Pharmaceutics"},{"issue":"11","key":"10.1016\/j.ncrna.2023.10.002_bib89","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1158\/2159-8290.CD-13-0159","article-title":"Therapeutic synergy between microRNA and siRNA in ovarian cancer treatment","volume":"3","author":"Nishimura","year":"2013","journal-title":"Cancer Discov."},{"issue":"2","key":"10.1016\/j.ncrna.2023.10.002_bib90","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/10408347.2020.1805293","article-title":"Liposomes: preparation, characteristics, and application strategies in analytical chemistry","volume":"52","author":"Liu","year":"2022","journal-title":"Crit. Rev. Anal. Chem."},{"key":"10.1016\/j.ncrna.2023.10.002_bib91","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejca.2021.10.011","volume":"160","author":"Schneeweiss","year":"2022","journal-title":"Eur. J. Cancer"},{"issue":"5","key":"10.1016\/j.ncrna.2023.10.002_bib92","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/17425247.2022.2075846","article-title":"Lipoplexes and polyplexes as nucleic acids delivery nanosystems: the current state and future considerations","volume":"19","author":"Costa","year":"2022","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.ncrna.2023.10.002_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemphyslip.2019.104837","article-title":"Lipid nanocarriers for microRNA delivery","volume":"226","author":"Scheideler","year":"2020","journal-title":"Chem. Phys. Lipids"},{"issue":"12","key":"10.1016\/j.ncrna.2023.10.002_bib94","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1007\/s00432-019-03051-6","article-title":"Therapeutic delivery of microRNA-143 by cationic lipoplexes for non-small cell lung cancer treatment in vivo","volume":"145","author":"Jiang","year":"2019","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ncrna.2023.10.002_bib95","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3390\/pharmaceutics12020189","article-title":"Sphingomyelin-based nanosystems (SNs) for the development of anticancer miRNA therapeutics","volume":"12","author":"Nagachinta","year":"2020","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.ncrna.2023.10.002_bib96","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00262-011-0970-1","article-title":"Enantiospecific adjuvant activity of cationic lipid DOTAP in cancer vaccine","volume":"60","author":"Vasievich","year":"2011","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.ncrna.2023.10.002_bib97","doi-asserted-by":"crossref","first-page":"237","DOI":"10.21873\/anticanres.13103","article-title":"Cell-penetrating peptide-coated liposomes for drug delivery across the blood-brain barrier","volume":"39","author":"Yuan","year":"2019","journal-title":"Anticancer Res."},{"issue":"3","key":"10.1016\/j.ncrna.2023.10.002_bib98","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4149\/neo_2013_036","article-title":"Regulation of epidermal growth factor receptor signaling by plasmid-based microRNA-7 inhibits human malignant gliomas growth and metastasis in vivo","volume":"60","author":"Wang","year":"2013","journal-title":"Neoplasma"},{"issue":"4","key":"10.1016\/j.ncrna.2023.10.002_bib99","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.tips.2017.01.003","article-title":"Cell-penetrating peptides: from basic research to clinics","volume":"38","author":"Guidotti","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.ncrna.2023.10.002_bib100","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1021\/acs.molpharmaceut.0c00160","article-title":"Improved cellular delivery of antisense oligonucleotide for miRNA-21 imaging in vivo using cell-penetrating peptide-based nanoprobes","volume":"18","author":"Yang","year":"2021","journal-title":"Mol. Pharm."},{"issue":"5","key":"10.1016\/j.ncrna.2023.10.002_bib101","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.822","article-title":"The role of cell-penetrating peptides in potential anti-cancer therapy","volume":"12","author":"Zhou","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.ncrna.2023.10.002_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118789","article-title":"Efficient delivery of anti-miR-210 using Tachyplesin, a cell penetrating peptide, for glioblastoma treatment","volume":"572","author":"Jana","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ncrna.2023.10.002_bib103","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jbiosc.2019.01.003","article-title":"Combined apoptotic effects of peptide and miRNA in a peptide\/miRNA nanocomplex","volume":"128","author":"Kim","year":"2019","journal-title":"J. Biosci. Bioeng."},{"issue":"24","key":"10.1016\/j.ncrna.2023.10.002_bib104","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1002\/asia.201801396","article-title":"Cell-selective delivery of MicroRNA with a MicroRNA-peptide conjugate nanocomplex","volume":"13","author":"Xiao","year":"2018","journal-title":"Chem. Asian J."},{"issue":"21\u201322","key":"10.1016\/j.ncrna.2023.10.002_bib105","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.drudis.2013.06.014","article-title":"Polymer gene delivery: overcoming the obstacles","volume":"18","author":"Aied","year":"2013","journal-title":"Drug Discov. Today"},{"issue":"45","key":"10.1016\/j.ncrna.2023.10.002_bib106","doi-asserted-by":"crossref","first-page":"13627","DOI":"10.1021\/acs.langmuir.2c02197","article-title":"Designed peptide assemblies for efficient gene delivery","volume":"38","author":"Ma","year":"2022","journal-title":"Langmuir"},{"issue":"4","key":"10.1016\/j.ncrna.2023.10.002_bib107","doi-asserted-by":"crossref","DOI":"10.17795\/ijcp-4190","article-title":"Effects of chrysin-PLGA-PEG nanoparticles on proliferation and gene expression of miRNAs in gastric cancer cell line","volume":"9","author":"Mohammadian","year":"2016","journal-title":"Iran. J. Cancer Prev."},{"issue":"12","key":"10.1016\/j.ncrna.2023.10.002_bib108","doi-asserted-by":"crossref","first-page":"5744","DOI":"10.1111\/jcmm.16595","article-title":"MicroRNA-181a\/b-1-encapsulated PEG\/PLGA nanofibrous scaffold promotes osteogenesis of human mesenchymal stem cells","volume":"25","author":"Qi","year":"2021","journal-title":"J. Cell Mol. Med."},{"issue":"3","key":"10.1016\/j.ncrna.2023.10.002_bib109","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10456-021-09778-6","article-title":"Hydrogel-mediated delivery of microRNA-92a inhibitor polyplex nanoparticles induces localized angiogenesis","volume":"24","author":"Radmanesh","year":"2021","journal-title":"Angiogenesis"},{"issue":"3","key":"10.1016\/j.ncrna.2023.10.002_bib110","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jconrel.2013.09.015","article-title":"Progress in microRNA delivery","volume":"172","author":"Zhang","year":"2013","journal-title":"J. Contr. Release"},{"issue":"12","key":"10.1016\/j.ncrna.2023.10.002_bib111","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1021\/acs.molpharmaceut.5b00694","article-title":"Nanoparticle-delivered antisense MicroRNA-21 enhances the effects of temozolomide on glioblastoma cells","volume":"12","author":"Ananta","year":"2015","journal-title":"Mol. Pharm."},{"issue":"9","key":"10.1016\/j.ncrna.2023.10.002_bib112","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1021\/acs.molpharmaceut.6b00388","article-title":"Tailored nanoparticle codelivery of antimiR-21 and antimiR-10b augments glioblastoma cell kill by temozolomide: toward a \"personalized\" anti-microRNA therapy","volume":"13","author":"Ananta","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ncrna.2023.10.002_bib113","unstructured":"Devulapally, R.; Sekar, N. M.; Sekar, T. V.; Foygel, K.; Massoud, T. F.; Willmann, J. K.; Paulmurugan, R. Polymer Nanoparticles Mediated Codelivery of AntimiR-10b and AntimiR-21 for Achieving Triple Negative Breast Cancer Therapy.."},{"key":"10.1016\/j.ncrna.2023.10.002_bib114","doi-asserted-by":"crossref","first-page":"21478","DOI":"10.18632\/oncotarget.25135","article-title":"Targeted nanoparticle delivery of therapeutic antisense microRNAs presensitizes glioblastoma cells to lower effective doses of temozolomide in vitro and in a mouse model","volume":"9","author":"Malhotra","year":"2018","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.ncrna.2023.10.002_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2022.103386","article-title":"Inorganic nanoparticle-based advanced cancer therapies: promising combination strategies","volume":"27","author":"Amaldoss","year":"2022","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.ncrna.2023.10.002_bib116","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1021\/acs.bioconjchem.6b00512","article-title":"Inorganic nanoparticles for image-guided therapy","volume":"28","author":"Yoon","year":"2017","journal-title":"Bioconjugate Chem."},{"issue":"7","key":"10.1016\/j.ncrna.2023.10.002_bib117","doi-asserted-by":"crossref","first-page":"5355","DOI":"10.1166\/jnn.2014.9076","article-title":"In vivo imaging of brain cancer using epidermal growth factor single domain antibody bioconjugated to near-infrared quantum dots","volume":"14","author":"Fatehi","year":"2014","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.ncrna.2023.10.002_bib118","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/978-3-319-72041-8_19","article-title":"Using of quantum dots in biology and medicine","volume":"1048","author":"Pleskova","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"issue":"18","key":"10.1016\/j.ncrna.2023.10.002_bib119","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810763","article-title":"Quantum dots and their interaction with biological systems","volume":"23","author":"Le","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ncrna.2023.10.002_bib120","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-017-0041","article-title":"A carbon nanotube reporter of miRNA hybridization events in vivo","volume":"1","author":"Harvey","year":"2017","journal-title":"Nat. Biomed. Eng."},{"issue":"5","key":"10.1016\/j.ncrna.2023.10.002_bib121","doi-asserted-by":"crossref","first-page":"620","DOI":"10.2174\/1567201815666171221124711","article-title":"Carbon nanotubes: classification, method of preparation and pharmaceutical application","volume":"15","author":"Rode","year":"2018","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.ncrna.2023.10.002_bib122","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/418624","article-title":"Gold nanoparticles inhibit VEGF165-induced migration and tube formation of endothelial cells via the Akt pathway","author":"Pan","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ncrna.2023.10.002_bib123","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.2147\/IJN.S241055","article-title":"Brain targeted gold liposomes improve RNAi delivery for glioblastoma","volume":"15","author":"Grafals-Ruiz","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ncrna.2023.10.002_bib124","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.750171","article-title":"miR-371b-5p-Engineered exosomes enhances tumor inhibitory effect","volume":"9","author":"Xue","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.ncrna.2023.10.002_bib125","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/neuonc\/nox152","article-title":"Mesenchymal stem cells as natural biofactories for exosomes carrying miR-124a in the treatment of gliomas","volume":"20","author":"Lang","year":"2018","journal-title":"Neuro Oncol."},{"issue":"2","key":"10.1016\/j.ncrna.2023.10.002_bib126","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ncrna.2022.02.005","article-title":"The role of microRNA in the pathogenesis of glial brain tumors","volume":"7","author":"Beylerli","year":"2022","journal-title":"Noncoding RNA Res."},{"issue":"3\u20134","key":"10.1016\/j.ncrna.2023.10.002_bib127","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ncrna.2017.12.002","article-title":"Translational applications of microRNAs in cancer, and therapeutic implications","volume":"2","author":"Kwok","year":"2017","journal-title":"Noncoding RNA Res."},{"issue":"1","key":"10.1016\/j.ncrna.2023.10.002_bib128","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s12935-022-02754-0","article-title":"A review on the role of mir-16-5p in the carcinogenesis","volume":"22","author":"Ghafouri-Fard","year":"2022","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ncrna.2023.10.002_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175388","article-title":"MicroRNA-based therapy for glioblastoma: opportunities and challenges","volume":"938","author":"Lei","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.ncrna.2023.10.002_bib130","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ncrna.2022.09.001","article-title":"MicroRNAs-mediated regulation of glucose transporter (GLUT) expression in glioblastoma","volume":"7","author":"Beylerli","year":"2022","journal-title":"Noncoding RNA Res."}],"container-title":["Non-coding RNA Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246805402300063X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246805402300063X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T04:30:18Z","timestamp":1762835418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S246805402300063X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":130,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S246805402300063X"],"URL":"https:\/\/doi.org\/10.1016\/j.ncrna.2023.10.002","relation":{},"ISSN":["2468-0540"],"issn-type":[{"value":"2468-0540","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methods of miRNA delivery and possibilities of their application in neuro-oncology","name":"articletitle","label":"Article Title"},{"value":"Non-coding RNA Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncrna.2023.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by KeAi Communications Co., Ltd.","name":"copyright","label":"Copyright"}]}}